Moerman P - Search Results

1

The diagnostic problem of endometrial stromal sarcoma: report on six cases.

Amant F, Moerman P, Cadron I, Neven P, Berteloot P, Vergote I. Amant F, et al. Among authors: moerman p. Gynecol Oncol. 2003 Jul;90(1):37-43. doi: 10.1016/s0090-8258(03)00207-5. Gynecol Oncol. 2003. PMID: 12821339 Review.

2

The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned.

Amant F, Vergote I, Moerman P. Amant F, et al. Among authors: moerman p. Gynecol Oncol. 2004 Nov;95(2):412-3; author reply 413. doi: 10.1016/j.ygyno.2004.07.021. Gynecol Oncol. 2004. PMID: 15491769 No abstract available.

3

Para-aortic lymph node metastases in locally advanced cervical cancer: Comparison between surgical staging and imaging.

Vandeperre A, Van Limbergen E, Leunen K, Moerman P, Amant F, Vergote I. Vandeperre A, et al. Among authors: moerman p. Gynecol Oncol. 2015 Aug;138(2):299-303. doi: 10.1016/j.ygyno.2015.05.021. Epub 2015 May 23. Gynecol Oncol. 2015. PMID: 26007204

4

Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.

Salihi R, Leunen K, Van Limbergen E, Moerman P, Neven P, Vergote I. Salihi R, et al. Among authors: moerman p. Gynecol Oncol. 2015 Dec;139(3):447-51. doi: 10.1016/j.ygyno.2015.05.043. Epub 2015 Jun 4. Gynecol Oncol. 2015. PMID: 26050921

5

Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies.

Depreeuw J, Hermans E, Schrauwen S, Annibali D, Coenegrachts L, Thomas D, Luyckx M, Gutierrez-Roelens I, Debruyne D, Konings K, Moerman P, Vergote I, Lambrechts D, Amant F. Depreeuw J, et al. Among authors: moerman p. Gynecol Oncol. 2015 Oct;139(1):118-26. doi: 10.1016/j.ygyno.2015.07.104. Epub 2015 Jul 29. Gynecol Oncol. 2015. PMID: 26232337

6

Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature.

Amant F, Moerman P, Cadron I, Hagemeijer A, Vergote I, Debiec-Rychter M. Amant F, et al. Among authors: moerman p. Gynecol Oncol. 2003 Mar;88(3):459-62. doi: 10.1016/s0090-8258(02)00096-3. Gynecol Oncol. 2003. PMID: 12648605 Review.

7

Transition of epithelial toward mesenchymal differentiation during ovarian carcinosarcoma tumorigenesis.

Amant F, Vloeberghs V, Woestenborghs H, Moerman P, Vergote I. Amant F, et al. Among authors: moerman p. Gynecol Oncol. 2003 Aug;90(2):372-7. doi: 10.1016/s0090-8258(03)00326-3. Gynecol Oncol. 2003. PMID: 12893202

8

Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.

Amant F, Schurmans K, Steenkiste E, Verbist L, Abeler VM, Tulunay G, De Jonge E, Massuger L, Moerman P, Vergote I. Amant F, et al. Among authors: moerman p. Gynecol Oncol. 2004 Jun;93(3):680-5. doi: 10.1016/j.ygyno.2004.03.021. Gynecol Oncol. 2004. PMID: 15196864

9

ERBB-2 gene overexpression and amplification in uterine sarcomas.

Amant F, Vloeberghs V, Woestenborghs H, Debiec-Rychter M, Verbist L, Moerman P, Vergote I. Amant F, et al. Among authors: moerman p. Gynecol Oncol. 2004 Dec;95(3):583-7. doi: 10.1016/j.ygyno.2004.07.041. Gynecol Oncol. 2004. PMID: 15581967

10

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.

Amant F, Cadron I, Fuso L, Berteloot P, de Jonge E, Jacomen G, Van Robaeys J, Neven P, Moerman P, Vergote I. Amant F, et al. Among authors: moerman p. Gynecol Oncol. 2005 Aug;98(2):274-80. doi: 10.1016/j.ygyno.2005.04.027. Gynecol Oncol. 2005. PMID: 15972232

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters